Home

Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 24/09/09

Trade details

Type
Insider sale
Amount
$25,240.32
Shares · price
2,191 sh · $11.52 a share
Held after
107,958 sh
Trade date
24/09/09
Filed
24/09/09
Days to filing
0 days

Sold 2.0% of holdings

Share of holding sold
2.0%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/10~24/10/09

Peter Heerma's recent trades

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $525.7K

    Filed 09/17

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $10.8M

    Filed 09/16

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $6.7M

    Filed 09/15

  • Peter Heerma

    SellTravere Therapeutics

    $101.4K

    Filed 05/06

  • Peter Heerma

    Planned saleTravere Therapeutics

    $101.4K

    Filed 05/05